Balchem Expands Functional Delivery Formats as Q3 Nutrition Revenue Hits $188M
Balchem reported an 8.1% increase in quarterly nutrition revenue to $188.2 million, led by active ingredients and microencapsulation technologies set for display at Fi Europe.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Frankfurt, Germany — 26 October 2026
Balchem will showcase functional food delivery formats and encapsulated processing aids at Fi Europe 2026 in Frankfurt, supported by an 8.1% year-on-year increase in third-quarter Human Nutrition & Health revenue to US$188.2 million. Segment operating earnings increased 11.8% to US$45.6 million, underpinned by favorable product mix across its nutrients and food ingredients portfolio. Group net sales reached US$290.7 million, up 8.6%, with net earnings rising 16.0% to US$46.7 million.
The company is broadening its traditional processing showcase to include branded active ingredients, pairing technical encapsulates with clinically positioned nutrients. Demonstrations scheduled for 17–19 November feature dark chocolate fortified with K2Vital (vitamin K2) for cardiovascular and bone support, alongside ready-to-drink functional beverages formulated with VitaCholine targeting cognitive and hepatic performance. For contract manufacturers, shifting these fat-soluble vitamins and hygroscopic choline salts into confectionery and liquid formats requires tight overage controls and barrier stability to prevent degradation across retail distribution cycles.
In meat processing, Balchem's MeatShure technology replaces conventional lactic acid fermentation in meat stick lines. By encapsulating acidulants, processors bypass time-intensive curing steps and eliminate the residual carbohydrates needed to feed starter cultures, creating immediate capacity on existing lines and permitting no-added-sugar claims in high-protein snacking ranges.
Complementing this, the BakeShure portfolio addresses sodium reduction targets in yeast-leavened bakery products. The encapsulation system isolates leavening acids and antimicrobials until thermal release during baking, extending mold-free shelf life in ambient and freezer-to-oven formats while protecting finished loaf volume and crumb elasticity.
What this means for Germany
German brand owners and co-packers face intensifying margin pressure as domestic grocery chains like dm-drogerie, Rossmann, and Rewe demand cleaner nutritional profiles. Incorporating K2Vital into premium confectionery offers high-margin differentiation under EFSA-approved bone health claim structures (Art. 13.1), bypassing generic supplement commoditisation. Meanwhile, MeatShure and BakeShure provide co-manufacturers with tangible operational cost offsets: reducing batch run-times on cured meat lines expands daily output without capital expenditure, while sodium-reduction systems help German processors comply with Federal Ministry of Food and Agriculture (BMEL) sodium reformulation targets without compromising retail shelf-life specifications.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.
This article does not constitute medical advice.